Avalo Therapeutics Inc (AVTX)
4.35 x 1 5.20 x 2
Pre-market by (Cboe BZX)
4.78 -0.10 (-2.05%) 04/25/25 [NASDAQ]
4.35 x 1 5.20 x 2
Pre-market 4.78 unch (unch) 16:00 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,129 | -31,544 | -41,658 | -84,376 | -63,500 |
| Depreciation Amortization | 169 | 5,893 | 1,555 | 2,451 | 1,843 |
| Income taxes - deferred | 114 | 14 | 28 | 22 | 197 |
| Accounts receivable | N/A | N/A | 1,060 | 1,117 | -678 |
| Accounts payable and accrued liabilities | -163 | -2,436 | -487 | 796 | 99 |
| Other Working Capital | -126,319 | -9,240 | 4,770 | 3,839 | -4,451 |
| Other Operating Activity | 112,272 | 6,633 | 7,981 | 5,259 | 25,951 |
| Operating Cash Flow | $-49,056 | $-30,680 | $-26,751 | $-70,892 | $-40,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 25 | -95 | -113 | -63 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 12,837 |
| Other Investing Activity | 356 | -158 | 0 | 0 | -1,642 |
| Investing Cash Flow | $356 | $-133 | $-95 | $-113 | $11,132 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -21,244 | N/A | N/A | N/A |
| Common Stock Issued | 69,443 | 46,286 | -14,699 | 106,762 | 40,990 |
| Other Financing Activity | 106,406 | 0 | 0 | 0 | 3,794 |
| Financing Cash Flow | $175,849 | $25,042 | $-14,699 | $106,762 | $44,784 |
| Beginning Cash Position | 7,547 | 13,318 | 54,863 | 19,106 | 3,729 |
| End Cash Position | 134,696 | 7,547 | 13,318 | 54,863 | 19,106 |
| Net Cash Flow | $127,149 | $-5,771 | $-41,545 | $35,757 | $15,377 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,056 | -30,680 | -26,751 | -70,892 | -40,539 |
| Capital Expenditure | N/A | N/A | -95 | -113 | -63 |
| Free Cash Flow | -49,056 | -30,680 | -26,846 | -71,005 | -40,602 |